| Systemic therapy and sequencing options in advanced hepatocellular carcinoma: a systematic review and network meta-analysis MB Sonbol, IB Riaz, SAA Naqvi, DR Almquist, S Mina, J Almasri, S Shah, ... JAMA oncology 6 (12), e204930-e204930, 2020 | 164 | 2020 |
| Immunotherapy for colorectal cancer: a review of current and novel therapeutic approaches AJ Franke, WP Skelton IV, JS Starr, H Parekh, JJ Lee, MJ Overman, ... JNCI: Journal of the National Cancer Institute 111 (11), 1131-1141, 2019 | 152 | 2019 |
| Total neoadjuvant therapy: a shifting paradigm in locally advanced rectal cancer management AJ Franke, H Parekh, JS Starr, SA Tan, A Iqbal, TJ George Jr Clinical colorectal cancer 17 (1), 1-12, 2018 | 115 | 2018 |
| Management of malignant bowel obstruction associated with GI cancers AJ Franke, A Iqbal, JS Starr, RM Nair, TJ George Jr Journal of oncology practice 13 (7), 426-434, 2017 | 89 | 2017 |
| 5-FU induced cardiotoxicity: case series and review of the literature C Yuan, H Parekh, C Allegra, TJ George, JS Starr Cardio-oncology 5, 1-7, 2019 | 68 | 2019 |
| Circulating tumor DNA profiling of advanced biliary tract cancers K Mody, PM Kasi, JD Yang, PK Surapaneni, T Bekaii-Saab, DH Ahn, ... JCO precision oncology 3, 1-9, 2019 | 61 | 2019 |
| Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers K Mody, J Starr, M Saul, K Poorman, BA Weinberg, ME Salem, ... Journal of gastrointestinal oncology 10 (6), 1099, 2019 | 54 | 2019 |
| Survival and incidence patterns of pancreatic neuroendocrine tumors over the last 2 decades: a SEER database analysis MB Sonbol, GL Mazza, L Mi, T Oliver, J Starr, H Gudmundsdottir, ... The oncologist 27 (7), 573-578, 2022 | 52 | 2022 |
| Peptide receptor radionuclide therapy for the treatment of pancreatic neuroendocrine tumors: recent insights JS Starr, MB Sonbol, TJ Hobday, A Sharma, AT Kendi, TR Halfdanarson OncoTargets and therapy, 3545-3555, 2020 | 44 | 2020 |
| Blood-based next-generation sequencing analysis of neuroendocrine neoplasms K Zakka, R Nagy, L Drusbosky, M Akce, C Wu, OB Alese, BF El-Rayes, ... Oncotarget 11 (19), 1749, 2020 | 43 | 2020 |
| Treatment outcomes of well‐differentiated high‐grade neuroendocrine tumors AJ Liu, BE Ueberroth, PW McGarrah, SA Buckner Petty, AT Kendi, J Starr, ... The oncologist 26 (5), 383-388, 2021 | 37 | 2021 |
| Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer S Chakrabarti, L Bucheit, JS Starr, R Innis-Shelton, A Shergill, H Dada, ... Journal for immunotherapy of cancer 10 (6), 2022 | 25 | 2022 |
| Circulating tumor DNA-based testing and actionable findings in patients with advanced and metastatic pancreatic adenocarcinoma G Botrus, H Kosirorek, MB Sonbol, Y Kusne, PLS Uson, MJ Borad, ... The Oncologist 26 (7), 569-578, 2021 | 25 | 2021 |
| Follicular dendritic cell sarcoma presenting as a thyroid mass JS Starr, S Attia, RW Joseph, D Menke, J Casler, RC Smallridge Journal of Clinical Oncology 33 (17), e74-e76, 2015 | 25 | 2015 |
| Cardiac morbidity and mortality in women with ductal carcinoma in situ of the breast treated with breast conservation therapy CK Park, X Li, J Starr, EER Harris The breast journal 17 (5), 470-476, 2011 | 22 | 2011 |
| Design and rational for the precision medicine guided treatment for cancer pain pragmatic clinical trial SA Mosley, JK Hicks, DG Portman, KA Donovan, P Gopalan, J Schmit, ... Contemporary clinical trials 68, 7-13, 2018 | 20 | 2018 |
| Extragastrointestinal stromal tumors of the pelvic cavity and the vagina: two case reports and review of the literature W Hanayneh, J Starr, TJ George Jr, H Parekh Gynecologic oncology reports 25, 3-7, 2018 | 19 | 2018 |
| Gemcitabine-induced chronic systemic capillary leak syndrome R Bajwa, J Starr, K Daily Case Reports 2017, bcr-2017-221068, 2017 | 19 | 2017 |
| Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors H Park, GI Shapiro, X Gao, A Mahipal, J Starr, M Furqan, P Singh, ... ESMO open 7 (5), 100573, 2022 | 18 | 2022 |
| Efficacy of checkpoint inhibitors in neuroendocrine neoplasms: mayo clinic experience JJ Gile, AJ Liu, PW McGarrah, RA Eiring, TJ Hobday, JS Starr, MB Sonbol, ... Pancreas 50 (4), 500-505, 2021 | 17 | 2021 |
